Siren, L.L.C. Cullinan Oncology, Inc. Transaction History
Siren, L.L.C.
- $1.93 Trillion
- Q2 2025
A detailed history of Siren, L.L.C. transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 1,193,410 shares of CGEM stock, worth $8.75 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
1,193,410
Previous 1,193,410
-0.0%
Holding current value
$8.75 Million
Previous $9.03 Billion
0.53%
% of portfolio
0.47%
Previous 0.51%
Shares
2 transactions
Others Institutions Holding CGEM
# of Institutions
151Shares Held
66.6MCall Options Held
10.6KPut Options Held
917K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$56.1 Million11.28% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$42.2 Million1.7% of portfolio
-
Lynx1 Capital Management LP San Juan, PR4.4MShares$32.3 Million9.81% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.86MShares$28.3 Million0.67% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$26 Million0.0% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $334M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...